Safety and Tolerability of Bone Marrow-Derived Allogeneic Mesenchymal Stem Cells in Parkinson's Disease Patients

被引：0
|
作者：
Schiess, Mya C. [1 ]
Suescun, Jessika [1 ]
Doursout, Marie-Francoise [1 ]
Adams, Christopher [1 ]
Green, Charles [1 ]
Saltarrelli, Jerome G. [1 ]
Savitz, Sean [1 ]
Ellmore, Timothy [2 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] CUNY, New York, NY 10021 USA
来源：
ANNALS OF NEUROLOGY | 2020年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
488
引用
收藏
页码：S186 / S187
页数：2
相关论文
共 50 条
  • [1] Safety and Tolerability of Bone marrow-derived Allogeneic Mesenchymal Stem Cells in Parkinson's disease Patients
    Schiess, Mya
    Suescun, Jessika
    Doursout, Marie-Francoise
    Adams, Christopher
    Green, Charles
    Saltarrelli, Jerome
    Ellmore, Timothy
    NEUROLOGY, 2020, 94 (15)
  • [2] Allogeneic bone marrow-derived mesenchymal stem cells safety and tolerability in idiopathic Parkinson's disease
    Schiess, M.
    Suescun, J.
    Doursout, M.
    Adams, C.
    Green, C.
    Saltarrelli, J.
    Savitz, S.
    Ellmore, T.
    MOVEMENT DISORDERS, 2020, 35 : S416 - S418
  • [3] Safety of Bone marrow-derived Allogeneic Mesenchymal Stem Cells in Parkinson's Disease Patients
    Schiess, M.
    Suescun, J.
    Ellmore, T.
    Doursout, M. F.
    Furr-Stimming, E.
    Mei, Z.
    Gee, A.
    MOVEMENT DISORDERS, 2019, 34 : S82 - S84
  • [4] Preliminary Report on the Safety and Tolerability of Bone marrow-derived Allogeneic Mesenchymal Stem Cells infused intravenously in Parkinson's disease Patients
    Schiess, Mya
    Suescun, Jessika
    Ellmore, Timothy
    Doursout, Marie-Francoise
    Furr-Stimming, Erin
    Miao, Hongyu
    Mei, Zhuyong
    Gee, Adrian
    NEUROLOGY, 2019, 92 (15)
  • [5] Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease
    Schiess, Mya
    Suescun, Jessika
    Doursout, Marie-Francoise
    Adams, Christopher
    Green, Charles
    Saltarrelli, Jerome G.
    Savitz, Sean
    Ellmore, Timothy M.
    MOVEMENT DISORDERS, 2021, 36 (08) : 1825 - 1834
  • [6] Preliminary Report on the Safety and Tolerability of Allogeneic Bone Marrow-derived Mesenchymal Stem Cells as a Disease-modifying Therapy for Parkinson's Disease: Phase IIa Double-blind, Randomized Controlled Trial
    Suescun, J.
    Ellmore, T.
    Adams, C.
    Thyne, V.
    Tharp, E.
    Chandra, S.
    Green, C.
    Shastri, R.
    Saltarrelli, J.
    Schiess, M.
    MOVEMENT DISORDERS, 2023, 38 : S53 - S53
  • [7] Bone marrow-derived mesenchymal stem cells
    Kemp, KC
    Hows, J
    Donaldson, C
    LEUKEMIA & LYMPHOMA, 2005, 46 (11) : 1531 - 1544
  • [8] Safety And Efficacy Of Allogeneic Bone Marrow-derived Mesenchymal Stem Cells In Neuromyelitis Optica Spectrum Disorder
    Kim, M.
    Nam, J.
    Lee, H.
    Lee, T.
    TISSUE ENGINEERING PART A, 2023, 29 (9-10)
  • [9] Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease
    Zhang, Zhiqing
    Wang, Xiaofang
    Wang, Suping
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2008, 44 (5-6) : 169 - 177
  • [10] Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson’s disease
    Zhiqing Zhang
    Xiaofang Wang
    Suping Wang
    In Vitro Cellular & Developmental Biology - Animal, 2008, 44 : 169 - 177
12345